Certolizumab Looks Promising for Moderate-to-Severe Psoriasis
Higher-dose certolizumab (400 mg) better at cutting symptoms than low-dose (200 mg)
Severe Atopic Eczema Tied to Higher CV Disease Risk
Risk of cardiovascular outcomes was greatest for those with the most active atopic eczema
CDC IDs Outbreak Trends Tied to Treated Recreational Water
Outbreaks with confirmed infectious etiology usually caused by Cryptosporidium, Legionella, Pseudomonas
Global Variation in Personal Health Care Access and Quality
Highest performance in Iceland, lowest in Central African Republic, with variation in rate of progress
Research Lacking on Platelet-Rich Tx for Facial Aesthetics, Alopecia
Procedure limited by the lack of standardized preparation, application methods
Congress Approves Bill Expanding Private Care for VA Patients
New bill would open up access to private doctors for veterans
CDC: No Change in Level of Uninsured in U.S. in 2017
Five percent of children uninsured in 2017, 41.3 and 55.0 percent had public and private coverage
Language Used in Medical Record Can Affect Patient Care
Stigmatizing language may transmit bias, influence trainees' attitudes
Sustained Use of Oxymetazoline Cream Efficacious for Rosacea
Findings based on year-long evaluation of safety and efficacy for moderate-to-severe symptoms
Best Practices Developed for Use of EHR to Enhance Patient Care
Patients regard EHR as positive presence; can be used to engage patients by jointly viewing data